What class of drug does the mixed amphetamine salts (e.g., Adderall) belong to?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Mixed Amphetamine Salts Drug Classification

Mixed amphetamine salts (Adderall) are classified as CNS stimulants and are Schedule II controlled substances. 1

Pharmacologic Classification

Mixed amphetamine salts belong to the psychostimulant class of medications, specifically categorized as sympathomimetic agents with central nervous system stimulant properties 2. The FDA labels explicitly identify these products as "Mixed Salts of a Single Entity Amphetamine Product" 1.

Specific Composition

The formulation contains a 3:1 ratio of dextroamphetamine to levoamphetamine, consisting of:

  • Dextroamphetamine saccharate
  • Amphetamine aspartate
  • Dextroamphetamine sulfate
  • Amphetamine sulfate 1, 3

This differs from pure dextroamphetamine formulations (like Dexedrine) which contain only the d-enantiomer 4.

Mechanism of Action

Amphetamines function primarily as dopamine and norepinephrine reuptake inhibitors with additional mechanisms including 5:

  • Vesicular monoamine transporter 2 (VMAT-2) inhibition
  • Monoamine oxidase activity inhibition
  • Indirect sympathomimetic effects

This distinguishes amphetamines from methylphenidate, which primarily acts through dopamine and norepinephrine transporter inhibition without the VMAT-2 effects 5.

Regulatory Status

All amphetamine formulations are Schedule II (CII) controlled substances under the Controlled Substances Act, reflecting their high potential for abuse and dependence 1. This classification requires special prescribing protocols and monitoring compared to lower schedule medications.

Clinical Context

Guidelines consistently classify stimulant medications (including amphetamines and methylphenidate) as first-line pharmacotherapy for ADHD, with effect sizes around 1.0 6. The stimulant class demonstrates superior efficacy compared to nonstimulant alternatives like atomoxetine (effect size ~0.7) 6.

References

2
Guideline

practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.

Journal of the American Academy of Child and Adolescent Psychiatry, 2002

Related Questions

What is the elimination half-life of immediate-release Adderall (mixed amphetamine salts) 5 mg?
Is taking 20 mg of Adderall (mixed amphetamine salts) three times a day appropriate?
For a patient taking 30 mg of immediate‑release Adderall (mixed amphetamine salts) who still experiences evening crashes, what medication can be used to prevent these crashes?
Can I start a 40-year-old patient on mixed amphetamine salts (Adderall) 10 mg twice daily?
A patient taking Adderall XR (mixed amphetamine salts extended‑release) 20 mg reports that the medication does not last through an eight‑hour work shift; how can the dose or regimen be adjusted to provide adequate coverage?
What is visual snow syndrome, how is it diagnosed, and what are the recommended management options?
What is the next best step in management for a 30-year-old man with crush injury to his legs, serum creatinine 2.8 mg/dL, creatine kinase 18 000 U/L, and dark orange (myoglobin‑stained) urine?
If a patient with a ureteral stone and upstream hydronephrosis has no evidence of infection, is hemodynamically stable, can tolerate oral intake, and has adequate pain control, can they be managed as an outpatient?
How do I calculate the continuous infusion pump rate for unfractionated heparin?
What are the differential diagnoses for a patient presenting with weakness, balance disturbance, collapse, and shortness of breath?
In a house‑fire survivor with no past medical history, who is intubated and receiving 100 % oxygen, with a serum lactate of 22 mmol/L and a PaO₂ of 45 mmHg, what is the next best step in management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.